JP2021502978A5 - - Google Patents

Download PDF

Info

Publication number
JP2021502978A5
JP2021502978A5 JP2020526473A JP2020526473A JP2021502978A5 JP 2021502978 A5 JP2021502978 A5 JP 2021502978A5 JP 2020526473 A JP2020526473 A JP 2020526473A JP 2020526473 A JP2020526473 A JP 2020526473A JP 2021502978 A5 JP2021502978 A5 JP 2021502978A5
Authority
JP
Japan
Prior art keywords
adeno
associated virus
virus vector
human
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020526473A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021502978A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/061319 external-priority patent/WO2019099696A1/en
Publication of JP2021502978A publication Critical patent/JP2021502978A/ja
Publication of JP2021502978A5 publication Critical patent/JP2021502978A5/ja
Priority to JP2023121924A priority Critical patent/JP7615238B2/ja
Pending legal-status Critical Current

Links

JP2020526473A 2017-11-15 2018-11-15 網膜ジストロフィーを治療するrdh12コード領域を含むウイルスベクターおよび方法 Pending JP2021502978A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023121924A JP7615238B2 (ja) 2017-11-15 2023-07-26 網膜ジストロフィーを治療するrdh12コード領域を含むウイルスベクターおよび方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762586624P 2017-11-15 2017-11-15
US62/586,624 2017-11-15
PCT/US2018/061319 WO2019099696A1 (en) 2017-11-15 2018-11-15 Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023121924A Division JP7615238B2 (ja) 2017-11-15 2023-07-26 網膜ジストロフィーを治療するrdh12コード領域を含むウイルスベクターおよび方法

Publications (2)

Publication Number Publication Date
JP2021502978A JP2021502978A (ja) 2021-02-04
JP2021502978A5 true JP2021502978A5 (https=) 2021-12-23

Family

ID=66431192

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020526473A Pending JP2021502978A (ja) 2017-11-15 2018-11-15 網膜ジストロフィーを治療するrdh12コード領域を含むウイルスベクターおよび方法
JP2023121924A Active JP7615238B2 (ja) 2017-11-15 2023-07-26 網膜ジストロフィーを治療するrdh12コード領域を含むウイルスベクターおよび方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023121924A Active JP7615238B2 (ja) 2017-11-15 2023-07-26 網膜ジストロフィーを治療するrdh12コード領域を含むウイルスベクターおよび方法

Country Status (27)

Country Link
US (2) US20190142909A1 (https=)
EP (2) EP4364803A3 (https=)
JP (2) JP2021502978A (https=)
KR (1) KR102704296B1 (https=)
CN (2) CN111886340A (https=)
AU (1) AU2018367606B2 (https=)
BR (1) BR112020009828A2 (https=)
DK (1) DK3710590T3 (https=)
EA (1) EA202091194A1 (https=)
ES (1) ES2983990T3 (https=)
FI (1) FI3710590T3 (https=)
HR (1) HRP20241073T1 (https=)
HU (1) HUE068393T2 (https=)
IL (2) IL308645B2 (https=)
LT (1) LT3710590T (https=)
MA (1) MA50914A (https=)
MX (2) MX2020005008A (https=)
MY (1) MY204271A (https=)
PH (1) PH12020551319A1 (https=)
PL (1) PL3710590T3 (https=)
PT (1) PT3710590T (https=)
RS (1) RS65881B1 (https=)
SG (1) SG11202004527YA (https=)
SI (1) SI3710590T1 (https=)
SM (1) SMT202400321T1 (https=)
WO (1) WO2019099696A1 (https=)
ZA (1) ZA202003416B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018009814A1 (en) 2016-07-08 2018-01-11 The Trustees Of The University Of Pennsylvania Methods and compositions for treatment of disorders and diseases involving rdh12
WO2022232249A1 (en) * 2021-04-27 2022-11-03 The Trustees Of Columbia University In The City Of New York Methods and compositions to regulate cholesterol efflux to prevent, treat, or cure macular degeneration
CN115725659A (zh) * 2022-04-01 2023-03-03 首都医科大学附属北京同仁医院 一种应用视网膜原位基因编辑制作非人灵长类动物先天性黑矇模型的方法
CN118453915A (zh) * 2024-04-29 2024-08-09 中国医学科学院北京协和医院 一种针对rdh12突变的基因治疗药物
CN120290554B (zh) * 2024-09-10 2026-04-14 广州市未来基因递送研究院 感光细胞特异性双向启动子及其用途
CN119432856B (zh) * 2024-12-30 2025-08-12 云舟生物科技(广州)股份有限公司 核酸分子、病毒颗粒及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120172419A1 (en) * 2009-09-15 2012-07-05 Medical College Of Wisconsin Research Foundation Inc. Reagents and methods for modulating cone photoreceptor activity
SG10201800541SA (en) * 2010-04-23 2018-03-28 Univ Florida Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)
WO2012167109A2 (en) 2011-06-03 2012-12-06 Massachusetts Eye & Ear Infirmary Rpgrip1 gene therapy for leber congenital amaurosis
EP2872183B1 (en) * 2012-07-11 2018-09-26 The Trustees Of The University Of Pennsylvania Aav-mediated gene therapy for rpgr x-linked retinal degeneration
WO2015075154A2 (en) 2013-11-20 2015-05-28 Fondazione Telethon Artificial dna-binding proteins and uses thereof
EP3800191B1 (en) 2014-03-17 2025-08-20 Adverum Biotechnologies, Inc. Compositions and methods for enhanced gene expression in cone cells
LT3137497T (lt) * 2014-05-02 2021-07-26 Genzyme Corporation Aav vektoriai, skirti tinklainės ir cns genų terapijai
GB201412011D0 (en) * 2014-07-04 2014-08-20 Ucl Business Plc Treatments
HUE068183T2 (hu) * 2014-07-24 2024-12-28 Massachusetts Eye & Ear Infirmary RPGR génterápia a retinitis pigmentosa terápiájára
US10392622B2 (en) 2014-08-01 2019-08-27 The Trustees Of The University Of Pennsylvania Compositions and methods for self-regulated inducible gene expression
EP3268481B1 (en) * 2015-03-11 2020-05-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Rpgr vectors for treating x-linked retinitis pigmentosa
EP3289080B1 (en) * 2015-04-30 2021-08-25 The Trustees of Columbia University in the City of New York Gene therapy for autosomal dominant diseases
WO2018009814A1 (en) 2016-07-08 2018-01-11 The Trustees Of The University Of Pennsylvania Methods and compositions for treatment of disorders and diseases involving rdh12
TR2021022284A2 (tr) 2021-12-31 2022-01-21 T C Ueskuedar Ueniversitesi Retinitis pigmentosa (rp) hastalığının tedavisinde kullanılmak üzere retinol dehidrojenaz 12 (rdh12) gen mutasyonlarına yönelik crıspr-pe sistemi.

Similar Documents

Publication Publication Date Title
JP2021502978A5 (https=)
JP7182873B2 (ja) 多重ベクターシステム及びその使用
JP2023093461A (ja) ハンチントン病治療組成物および方法
Trapani et al. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease
EP3151866B1 (en) Chimeric capsids
JP6805174B2 (ja) 神経成長因子シグナルペプチド及び副甲状腺ホルモンを含むaav分離株及び融合タンパク質
McClements et al. Gene therapy for retinal disease
JP2020073536A5 (https=)
JP2015523379A5 (https=)
IL274609B2 (en) Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies
JP2017523239A5 (https=)
RU2019100525A (ru) Векторная система на основе аденоассоциированного вируса
EP2262899A1 (en) Method of treating genetic disorders
CA3133555A1 (en) Triple helix terminator for efficient rna trans-splicing
JP7671790B2 (ja) 眼疾患の遺伝子治療
JP2022535412A5 (https=)
JP2019524090A5 (https=)
JP2018526994A5 (https=)
JP2019520405A5 (https=)
JP2021533801A5 (https=)
JP2018509154A5 (https=)
JP2021534796A5 (https=)
US20170137480A1 (en) Rpgr-ofr15 variant gene in the treatment of retinitis pigmentosa
WO2016073900A1 (en) Compositions and methods of treating usher syndrome iii
CN108103096B (zh) 一种先天性黒曚症的基因治疗药物